Clinical trial
Evaluation of Therapeutic Effects of ZAX.1400.P03 a Herbal Compound on Clinical Signs of Skin in Psoriasis Patients
NCT06301997 is registered in ClinicalTrials.gov with Fasa University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Therapeutic Effects of ZAX.1400.P03 a Herbal Compound on Clinical Signs of Skin in Psoriasis Patients
- Lead sponsor
- Fasa University of Medical Sciences
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- February 1, 2023
- Completion date
- July 30, 2025
- Enrollment
- 104 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.